CLINICAL_TRIALS
trial_result
· 2019-09-23
Clinical Trial Update: Long-Term Assessment of Remyelinating Therapy [Phase 2]
Summary
Phase 2 clinical trial assessing a remyelinating therapy for acute optic neuritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Biogen | Conditions: Acute Optic Neuritis | Phase 2 | Status: COMPLETED | Results posted: 2019-09-23